280582-25-4 Usage
Uses
Used in Pharmaceutical Synthesis:
2,4-dichloro-5-ethoxypyriMidine is used as an intermediate in the production of various pharmaceuticals for its ability to contribute to the molecular structure of potential therapeutic agents.
Used in Agrochemical Synthesis:
2,4-dichloro-5-ethoxypyriMidine is utilized as an intermediate in the synthesis of agrochemicals, particularly fungicides, due to its chemical properties that can be harnessed to create effective antifungal agents.
Used in Herbicide Production:
2,4-dichloro-5-ethoxypyriMidine is used as an active ingredient in herbicides, capitalizing on its broad-spectrum activity to control a wide range of weeds, thereby enhancing crop productivity.
Used in Organic Synthesis:
As a building block in organic synthesis, 2,4-dichloro-5-ethoxypyriMidine is used for the development of new drugs and pesticides, leveraging its molecular structure to create innovative and effective compounds.
Safety Considerations:
It is important to handle 2,4-dichloro-5-ethoxypyriMidine with care due to its toxicity to aquatic life and potential to cause skin and eye irritation, adhering to proper safety protocols during its use in chemical and industrial processes.
Check Digit Verification of cas no
The CAS Registry Mumber 280582-25-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,0,5,8 and 2 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 280582-25:
(8*2)+(7*8)+(6*0)+(5*5)+(4*8)+(3*2)+(2*2)+(1*5)=144
144 % 10 = 4
So 280582-25-4 is a valid CAS Registry Number.
280582-25-4Relevant academic research and scientific papers
NOVEL PYRIMIDINE COMPOUNDS AS MTOR AND P13K INHIBITORS
-
Page/Page column 142, (2011/07/30)
The present invention relates to pyrimidine compounds of formula (I): which are useful in treating mTOR kinase- or PI3K kinase-related diseases.
2,4-diamino pyrimidine compounds having anti-cell proliferative activity
-
, (2008/06/13)
A pyrimidine derivative of formula (I): wherein: R1is an optional substituent as defined within; Rxis selected from halo, hydroxy, nitro, amino, cyano, mercapto, carboxy, sulphamoyl, formamido, ureido or carbamoyl or a group of formula (Ib): A—B—C— as defined within; Q1and Q2are independently selected from aryl, a 5- or 6-membered monocyclic moiety; and a 9- or 10-membered bicyclic heterocyclic moiety; and one or both of Q1and Q2bears on any available carbon atom one substituent of formula (Ia) as defined within; and Q1and Q2are optionally further substituted; or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof; are useful as anti-cancer agents; and processes for their manufacture and pharmaceutical compositions containing them are described.
